您的位置: 首页 > 农业专利 > 详情页

Vacunas líquidas para múltiples serogrupos meningocócicos
专利权人:
NOVARTIS VACCINES AND DIAGNOSTICS S.R.L.
发明人:
CONTORNI, MARIO
申请号:
ES04791703
公开号:
ES2397923T3
申请日:
2004.10.04
申请国别(地区):
ES
年份:
2013
代理人:
摘要:
An aqueous immunogenic composition which, after administration to a subject, is able to induce an immune response that is bactericidal against serogroups B, C, W135 and Y of N. meningitidis, the composition comprising: (i) a saccharide antigen capsular serogroup C conjugate (Ii) a capsular saccharide antigen from serogroup W135 conjugate (Iii) a capsular saccharide antigen from serogroup Y conjugate and (iv) a protein "NadA" in oligomeric form, a protein "741," a protein "936," a protein "953" and a protein 287, wherein: NadA has an amino acid sequence: (a) has 50% or more identity with SEQ ID NO: 2 and / or (b) comprises a fragment of at least 7 consecutive amino acids of SEQ ID NO: 1 and comprising an epitope of SEQ ID NO: 1 741 has an amino acid sequence which: (a) has 50% or more identity with SEQ ID NO: 3 and / or (b) comprises a fragment of at least 7 consecutive amino acids of SEQ ID NO: 3 and comprising an epitope of SEQ ID NO: 3 936 has an amino acid sequence which: (a) has 50% or more identity with SEQ ID NO: 4 and / or (b) comprises a fragment of at least 7 consecutive amino acids of SEQ ID NO: 4 and comprising an epitope of SEQ ID NO: 4 953 has an amino acid sequence which: (a) has 50% or more identity with SEQ ID NO: 5 and / or (b) comprises a fragment of at least 7 consecutive amino acids of SEQ ID NO: 5 and comprising an epitope of SEQ ID NO: 5 287 has an amino acid sequence which: (a) has 50% or more identity with SEQ ID NO: 6 and / or (b) comprises a fragment of at least 7 consecutive amino acids of SEQ ID NO: 6 and comprising an epitope from SEQ ID NO: 6 and one or more antigens capsular saccharides from serogroup C, W135 and Y are O-acetylated.Una composición inmunogénica acuosa que, después de su administración a un sujeto, es capaz de inducir una respuesta inmune que es bactericida frente a los serogrupos B, C, W135 y Y de N. meningitidis, comprendiendo la composición: (i) un antígeno sacárido capsular del serogrupo C conjugado (ii) un antígeno
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充